首页> 美国卫生研究院文献>European Journal of Case Reports in Internal Medicine >D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients
【2h】

D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

机译:随时间推移D-二聚体和C反应蛋白血水平可用于预测两名COVID-19患者的肺栓塞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The diagnosis of pulmonary embolism is challenging in symptomatic COVID-19 patients since shortness of breath, chest pain, tachycardia, tachypnoea, fever, oxygen desaturation and high D-dimer blood levels might be features of both diseases. We present two COVID-19 patients in whom pulmonary embolism was suspected (and diagnosed) due to a discrepancy between an increase in D-dimer blood levels and a decrease in C-reactive protein blood levels over time. We believe that an opposite change in the blood levels of both biomarkers over time may be used as a novel method to predict pulmonary embolism in COVID-19 patients.
机译:有症状的COVID-19患者的肺栓塞诊断具有挑战性,因为呼吸急促,胸痛,心动过速,心动过速,发烧,氧饱和度降低和D-二聚体血液水平高可能是这两种疾病的特征。我们介绍了两名COVID-19患者,由于D-二聚体血液水平的升高与C反应蛋白血液水平的降低之间存在差异,因此怀疑(并诊断为)肺栓塞。我们相信,随着时间的推移,两种生物标志物血液水平的相反变化都可以用作预测COVID-19患者肺栓塞的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号